13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research



    ACTRN/NCT /ethics: 

    Scientific title: 


    Summary of trial and patient characteristics

    Cancer Type Pancreas
    Trial Type Treatment
    Phase Phase II, Phase III Tumour Stream Pancreas
    Age Range 18 years and older Cancer Stage In Situ
    Sex Both Anticipated Start Date 2018-03-26
    Molecular Target Anticipated End Date
    Cancer Type Pancreas
    Trial Type Treatment
    Phase Phase II, Phase III
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Pancreas
    Cancer Stage In Situ
    Anticipated Start Date 2018-03-26
    Anticipated End Date

    Trial Summary

    Pancreatic cancer cells have DNA mutations that are not present in normal cells. For some people, cancer-specific DNA can be found circulating in their bloodstream after they had surgery to remove their pancreatic cancer. This tumour-specific DNA may be evidence that some cancer cells have escaped before the pancreatic cancer was removed. The DYNAMIC-Pancreas study aims to see whether a test called “circulating tumour DNA” can be used to decide the type and duration of post-surgery chemotherapy.

    Lay Summary


    Sponsor / Cooperative group

    Marcus Foundation

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Dr Amitesh Roy Recruiting